Zura Bio Ltd financial data

Symbol
ZURA on Nasdaq
Location
4225 Executive Square, Suite 600, La Jolla, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 766 % -8.16%
Debt-to-equity 16.3 % -4.11%
Return On Equity -49.6 % -14.3%
Return On Assets -39.8 % -20.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 65M shares -0.41%
Common Stock, Shares, Outstanding 65M shares -0.42%
Entity Public Float 206M USD -42.3%
Common Stock, Value, Issued 7K USD 0%
Weighted Average Number of Shares Outstanding, Basic 94.6M shares +8.28%
Weighted Average Number of Shares Outstanding, Diluted 94.6M shares +8.28%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 40.4M USD +82.8%
General and Administrative Expense 32.2M USD +14.2%
Operating Income (Loss) -72.6M USD -44.3%
Nonoperating Income (Expense) 7.47M USD +146%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -65.1M USD -37.8%
Net Income (Loss) Attributable to Parent -65.1M USD -37.8%
Earnings Per Share, Basic 0 USD/shares -142%
Earnings Per Share, Diluted 0 USD/shares -142%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 139M USD -26.1%
Assets, Current 142M USD -24.7%
Property, Plant and Equipment, Net 131K USD +198%
Other Assets, Noncurrent 1.51M USD +2808%
Assets 144M USD -23.9%
Accounts Payable, Current 3.28M USD +223%
Liabilities, Current 25.5M USD +39.7%
Liabilities 25.5M USD +39.7%
Retained Earnings (Accumulated Deficit) -207M USD -45.8%
Stockholders' Equity Attributable to Parent 108M USD -29.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 110M USD -28.8%
Liabilities and Equity 144M USD -23.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.1M USD -122%
Net Cash Provided by (Used in) Financing Activities 5.18M USD
Net Cash Provided by (Used in) Investing Activities -49K USD +99%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 65M shares -0.42%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 139M USD -26.1%
Deferred Tax Assets, Valuation Allowance 25.7M USD +43.4%
Deferred Tax Assets, Gross 25.7M USD +43.4%
Payments to Acquire Property, Plant, and Equipment 49K USD +600%
Deferred Tax Assets, Operating Loss Carryforwards 6.01M USD -13.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 316M USD +6.87%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 9K USD
Share-based Payment Arrangement, Expense 12.6M USD -23.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%